Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
A Pharmacokinetic/Pharmacodynamic (PK/PD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to <12 Months of Age With Confirmed Flu Infection
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Influenza Virus Vaccines in Children and Adults
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older
- Status
- COMPLETED
- Phase
- PHASE2
Swine Flu (Novel Influenza A H1N1) Vaccine Study
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults
- Status
- COMPLETED
- Phase
- PHASE2
Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir
- Status
- COMPLETED
- Phase
- PHASE4
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
- Status
- TERMINATED
- Phase
- PHASE3
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1)
- Status
- COMPLETED
- Phase
- PHASE3
Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age
- Status
- COMPLETED
- Phase
- PHASE2
A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older
- Status
- TERMINATED
- Phase
- PHASE3
Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults
- Status
- COMPLETED
- Phase
- PHASE3
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3